Kamada (KMDA) vs Tilray Brands (TLRY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kamada (KMDA) has outperformed Tilray Brands (TLRY) over the past year, gaining 18.6% versus a loss of 78.3%. Over five years, KMDA leads with a +49.7% price change compared with -96.4% for TLRY. Tilray Brands is the larger company by market cap ($530.5 million vs $448.4 million), about 1.2 times the size.
On valuation, Kamada trades at a lower forward P/E (13.5x vs 20.2x for Tilray Brands). Kamada pays a dividend yielding 3.22%, while Tilray Brands does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KMDA | TLRY |
|---|---|---|
| Share price | $7.77 | $3.59 |
| Market cap | $448.41M | $530.52M |
| 1-day change | -1.52% | -3.37% |
| YTD return | +11.76% | -58.86% |
| 1-year return | +18.65% | -78.27% |
| 5-year return | +49.72% | -96.37% |
| P/E ratio (TTM) | 20.45 | — |
| Forward P/E | 13.47 | 20.22 |
| EPS (TTM) | $0.38 | $-1.09 |
| Dividend yield | 3.22% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| 52-week high | $9.35 | $23.20 |
| 52-week low | $6.55 | $3.38 |
| Distance from 52-week high | -16.90% | -84.53% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +73.75% | +99.45% |
| Average volume | 118.04K | 4.07M |
| Shares outstanding | 57.71M | 147.78M |
| Employees | 462 | 3,595 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KMDA has outperformed TLRY by 96.9 percentage points over the past year.
- Kamada offers a meaningfully higher dividend yield (3.22% vs 0.00%).
About Kamada
KMDA stock →Kamada Ltd. manufactures and sells plasma-derived protein therapeutics.
Health Care · Biotechnology: Pharmaceutical Preparations · 462 employees
About Tilray Brands
TLRY stock →Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Health Care · Medicinal Chemicals and Botanical Products · 3,595 employees
KMDA vs TLRY FAQ
Which is bigger, Kamada or Tilray Brands?
Tilray Brands (TLRY) is larger, with a market capitalization of $530.52M compared with $448.41M for Kamada (KMDA).
Which stock has performed better over the past year, KMDA or TLRY?
KMDA returned +18.65% over the past 12 months, compared with -78.27% for TLRY (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Kamada or Tilray Brands?
Kamada pays a dividend yielding 3.22%, while Tilray Brands does not currently pay a regular dividend.
Are Kamada and Tilray Brands in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Kamada and Medicinal Chemicals and Botanical Products for Tilray Brands.